Castle Biosciences To Present At The Canaccord Genuity 2015 Medical Technology & Diagnostics Forum
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that Derek Maetzold, President and CEO, will be presenting at the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum on Thursday, November 19th, 2015 at 1:00 p.m. EST in New York.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.